Cont: The One Covid-19 Science and Medicine Thread Part 5

From Marting's first link to the flu season of 2019-20. (I think most people are aware that COVID-19 didn't make much of an impact until the end of that season, or, if it did, C19 cases might have been misinterpreted as influenza.)
Yeah. And maybe Flu deaths were misinterpreted asCovid-19 deaths. Bias much? However, I think neither happened to any significant degree. I trust the CDC's Flu mortality burden estimates.

Marting's bias is conspicuous when he stresses only one side of the equation: "diagnosed flu deaths have been very undercounted in the USA. Not nearly as much as Covid which is regularly tested in all hospitals/urgent care."
Why not quote what the site actually says? Why come up with this biassed summary?

Really? I wasn't choosing 2019/2020 to consider Covid at all. It was just the last Flu season that pretty much ended before the Covid-19 pandemic took off in the USA. It was only for getting typical Flu mortality estimates from the official source. Further, the overall Flu mortality burden in that season was about 25k which is pretty typical of Flu mortality burdens in 10 years prior. In what way is that a bias?

2019-20 when C19 wasn't in the game until the end of the season and testing for it wasn't in place is probably the most idiotic year to use as a comparison of the death toll of the two diseases, flu and C19. The following seasons, when C19 was there from the beginning, show a very different picture: While COVID-19 was killing hundreds of thousands of people, both before and after the mRNA shots, "there was very little flu activity across the United States."

Good grief. The Flu 2019/20 season comparison was against the Covid-19 full, 2023 year. By that time Covid hospital testing was pretty universal. And it showed the rapid decrease of Covid-19 deaths from the first 2 years of the pandemic.

There may well be additional deaths ascribed to Covid-19 undercounts or sequelae as time goes on. But that would have to be pretty significant to flip the CDC Covid numbers I posted. Even with some increase, it sure seems like Covid-19 had, in 2023, similar if not less mortality* compared to that of normal influenza years.

*for those under 65. Obviously significantly higher for those over 65.
 
Last edited:
Meanwhile on the Long Covid front, Eric Topol summarizes new studies here:

https://erictopol.substack.com/p/new-insights-into-acute-and-long

Summing Up
SARS-CoV-2 is still evolving, and by selection will continue to find ways to induce (re-)infections despite global complacency. We’re making progress in elucidating the genesis of Long Covid, with a pair of studies that incriminate autoimmunity as a culprit. At the same time, we’re learning about ways to protect from infection (particularly IFN-1) and how to reduce the chances of central nervous system involvement by vaccination. These are all important steps of progress.
 
Eganelisib

"Targeting an enzyme called phosphatidylinositol 3,4,5-kinase gamma (PI3Kγ) with the small molecule inhibitor eganelisib—a clinical-stage anti-cancer agent developed by Infinity Pharmaceuticals, which declared Chapter 11 bankruptcy in October 2023—reduced the number of myeloid cells in the lungs and improved the survival rate of mice infected with either COVID-19 or MRSA...Stopping PI3Kγ’s activity stops myeloid cell migration, ameliorating tissue damage." Link

It is noteworthy how some drugs get a second chance at becoming commercially successful.
 
ZDoggMD finally gets Covid after 4.5 years.
https://www.youtube.com/watch?v=0t3CqFYeaVo

I like this video because it gives the doctor's perspective on the symptoms and how it differs from other illnesses. Interesting fellow because he is friends with both Dr. Paul Offit and Dr. Vinay Prasad. Very reasonable doc though I'm not into the mediation stuff that seems to fascinate him.


His daughter got Covid at camp a few days earlier, came home, then he got it. She tested positive with a rapid test. Initial rapid test for ZDoggMD was totally negative even though he had strong symptoms then strong positive the next day. Has some distortion in sense of smell/taste. Typical range of symptoms. Is recovering. Says he will report on any long term issues.

His wife hasn't gotten Covid and still is negative. She also had current boosters. ZDoggMD has not had recent boosters.
 
Last edited:
A study of German youth with presymptomatic type 1 diabetes links COVID-19 infection to accelerated progression to clinical diabetes.
For the study, published yesterday in JAMA, researchers in Munich and Dresden followed up with 509 children aged 1 to 16 years with presymptomatic type 1 diabetes participating in a screening program from February 2015 to October 2023.
(...)
"The incidence of type 1 diabetes increased during the COVID-19 pandemic," the study authors noted, and they sought to determine if COVID-19 contributed to the rise.

Faster progression only among infected youth
Fifty-seven of 358 participants (15.9%) progressed to clinical type 1 diabetes before the pandemic, while 113 of 396 (28.5%) did so after the pandemic began. The incidence of clinical type 1 diabetes was 6.4 per 100 person-years prepandemic and 12.1 per 100 after March 2020.
"The COVID-19 pandemic was associated with an accelerated progression to clinical disease and that this acceleration was confined to those with COVID-19."

COVID tied to faster progression from preclinical to clinical type 1 diabetes in kids (CIDRAP, July 16, 2024)


Notice that it seems to contradict the idea that the accelerated progression of presymptomatic type 1 diabetes to clinical disease could have been due to restrictions, lockdowns, 'immunity debt' or any of the excuses that minimizers come up with when they claim that attempts to mitigate the pandemic are worse than the pandemic, i.e. the infection, itself.
 
Previous research has shown that people with long COVID have elevated levels of IFN-γ, and evidence also suggests that the protein can contribute to injuries in the alveoli3 — the delicate air sacs in the lungs that move gases into and out of the bloodstream. But these studies could not determine whether IFN-γ is a cause of lung damage associated with long COVID or just an indication of another mechanism.
To investigate this, Sun and his colleagues took a two-step approach. First, they recruited people with long COVID and compared samples of cells from their lungs with those of people who had recovered from COVID-19 a few weeks before the study, as well as a controls who hadn’t been infected. They used a technique called single-cell RNA sequencing to analyse the make-up of the lung-cell samples. They discovered that samples from people with long COVID had higher levels of IFN-γ-producing T cells than did samples from people without COVID-19, or those who had recovered from the infection.
Then, the researchers infected mice with SARS-CoV-2. Twenty-one days after infection, the mice had a cellular response in their lungs similar to that seen in people with long COVID, including elevated levels of IFN-γ-producing T cells.
Long COVID lung damage linked to immune system response (Nature, July 18, 2024)
IFN-γ (Wiki)

So much for the idea that Long COVID is psychogenic.
 
President Joe Biden: "The pandemic is over." (Sep 20, 2022)
The pandemic (KP.2.3): "President Joe Biden is over." (July 20, 2024)
Philip K. Dick: "Reality is that which, when you stop believing in it, doesn't go away."

In case anybody is interested in the variant that got Biden.
On July 11, KP.2.3. was just "another variant":
A Yale Medicine expert weighs in on the potential impact of the new strains on the spread of COVID.
(...)
2. What do we know—and not know—about the FLiRT and LB.1 variants?
We know the FLiRT variants have two mutations on their spike proteins (the spike-shaped protrusions on the surface of the virus) that weren’t seen on JN.1 (the previously dominant strain in the U.S.). Some experts say these mutations could make it easier for the virus to evade people’s immunity—from the vaccine or a previous bout of COVID.
While more research is needed, experts suspect that the LB.1 strain and another variant called KP.2.3, which also has the two FLiRT mutations plus an additional one, may be more transmissible as well.
But, the fact that the variants are otherwise genetically similar to JN.1 should be reassuring, Dr. Roberts says. "While JN.1 occurred during the winter months, when people gather indoors and the virus is more likely to spread, its symptoms were milder than those caused by variants in the early years of the pandemic," he says.
There is no conclusive information yet about whether a COVID illness will be more severe with the new variants or how symptoms might change. Because everyone is different, a person’s symptoms and the severity of their COVID disease usually depend less on which variant they are infected with and more on their immunity and overall health, the CDC says.
3 Things to Know About FLiRT and LB.1, the New Coronavirus Strains (Yale Medicine, July 11, 2024)


I think it's a fairly safe bet to say that Biden and those close to him were up to date with their C19 vaccinations, which would confirm that "these mutations could make it easier for the virus to evade people’s immunity—from the vaccine or a previous bout of COVID."
 
Why spread disinformation like this?
There was probably a team of medical specialists lined up to make sure that Biden was fed Paxlovid immediately after he tested positive.
I don't know why The Atheist seems to think that KP.2.3. is more dangerous than previous variants. That is not what the article (or the quotation) says:
"There is no conclusive information yet about whether a COVID illness will be more severe with the new variants or how symptoms might change."
 
Why spread disinformation like this?

Sorry love, there's only one of us panicking about covid.

Hint: it's not me.

Covid is either a deadly disease we must stop at all costs, or it's an endemic disease we have to live with.

Which is it?
 
IFN-γ (Wiki)

So much for the idea that Long COVID is psychogenic.

You make the mistaken assumption that 'psychogenic' conditions are not associated with abnormalities of biochemistry / immunology. Abnormalities of hormones, immunity, cytokines are well described in depression.
 
No, I don't.
psychogenic (adjective): originating in the mind or in mental or emotional conflict
Psychogenic: Definition & Meaning (Merriam-Webster)
Classified as a "conversion disorder" by the DSM-IV, a psychogenic disease is a condition in which mental stressors cause physical symptoms matching other disorders. The manifestation of physical symptoms without biologically identifiable cause results from disruptions in normal brain function due to psychological stress.
Psychogeni disease (Wikipedia)


You are making the mistaken assumption that psychogenic is the same as psychosomatic.
However:
The term psychogenic disease is often used similarly to psychosomatic disease. However, the term psychogenic usually implies that psychological factors played a key causal role in the development of the illness. The term psychosomatic is often used more broadly to describe illnesses with a known medical cause where psychological factors may nonetheless play a role (e.g., asthma as exacerbated by anxiety).
 
Sorry love, there's only one of us panicking about covid.
Hint: it's not me.


Yes, it's none other than The Atheist panicking again.
I think he should get a grip on himself. I don't think anybody here is his love. If somebody is, I am certainly not the one. I am also not his 'mate', another one of those terms he likes to use disparagingly because he has neither facts nor arguments on his side.
He can't let go of those techniques.

Covid is either a deadly disease we must stop at all costs, or it's an endemic disease we have to live with.
Which is it?


It isn't any of them. The Atheist appears to be ignorant of the either-or fallacy (Quillbot, June 26, 2024):
The either-or fallacy, alternatively called false dilemma, false dichotomy, or false binary, leads to oversimplified conclusions that are often misleading and promote a closed-minded outlook.


Indeed!
 
Last edited:
This is gold. The panic-merchants are going to need something else to panic about.

Conclusions and Relevance In this prospective cohort study, there was no evidence that the proportion of participants with ME/CFS-like illness differed between those infected with SARS-CoV-2 vs those without SARS-CoV-2 infection up to 12 months after infection. A 3% to 4% prevalence of ME/CFS-like illness after an acute infection–like index illness would impose a high societal burden given the millions of persons infected with SARS-CoV-2.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2821459#:
 
This is gold! The Long-Covid deniers will love it!

Recruitment occurred in person, by email or telephone, and through electronic advertisement. A secure online platform (Hugo; Hugo Health LLC) facilitated collection of consent and survey distribution. Participants self-enrolled by first completing an online eligibility screener, during which they were asked to self-report COVID-19–like symptoms that they experienced within the past 42 days and provide documentation of their valid COVID-19 test and test result.
(...)
The INSPIRE study included adult participants (aged ≥18 years) who were fluent in English or Spanish, had access to an internet-enabled device to allow for participation, and had self-reported symptoms suggestive of acute SARS-CoV-2 infection at the time of their SARS-CoV-2 test.
(...)
Participants completed surveys at baseline and at 4 quarterly follow-up times. Participants self-reported sociodemographic data, including age, gender (female, male, or transgender, nonbinary, or other gender), race (Asian, Native Hawaiian, or Other Pacific Islander; Black or African American; White; or other
(...)
Because ME/CFS diagnosis requires a full clinical evaluation to identify treatable conditions contributing to symptoms used in diagnosis, the self-reported information in this study only allowed determination of ME/CFS-like illness, hereafter referred to as ME/CFS.


This is what The Atheist thinks of other studies based on self-reported symptoms:
Aside from it being self-reported and therefore irrelevant, the numbers would be expected to increase after a fairly large wave. The only interesting point is it shows 2/3 of alleged long covid sufferers having recovered completely.


This was also interesting:
Our study design required an acute infection prompting COVID-19 testing. While participants testing positive had an identifiable infection (SARS-CoV-2), we were unable to collect data on the specific infection that led to symptoms from those testing negative. Our finding that ME/CFS-like illness was equally likely to occur after SARS-CoV-2 and unknown infection[/hilitte] is similar to findings in a prospective, population-based study of acute respiratory illness in adults in the UK that found symptom burdens to be similar among participants with and without prior SARS-CoV-2 infection.20 In contrast, a large retrospective analysis of electronic health records conducted in the UK in 2020 suggested that SARS-CoV-2 infection resulted in significantly more postacute symptoms than did influenza, although symptoms were also common following influenza.21 However, that study’s definition of ME/CFS was reliant on symptom documentation in electronic health records, which can vary based on clinician expectations and inquiry about postinfectious symptoms in patients with SARS-CoV-2 infection compared with influenza.
I don't think The Atheist has considered the difference between an infectious disease that people may have once every five to ten years, and one they may have several times in the short span of years that SARS-CoV-2 has existed, even if each infection leaves patients with the same number and severity of post acute symptoms.
 
Hearing loss in young adults after C19 infections

We knew about loss of smell and taste with Covid infections.
A nationwide report from S Korea found a 3.5-fold increase in hearing loss among young adultshttps://thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00338-9/fulltext
Eric Topol (X, July 30, 2024)


Background
The association of COVID-19 with hearing loss (HL) is unclear among young adults and needs to be investigated. This study was conducted to determine the association of COVID-19 with HL and sudden sensorineural hearing loss (SSNHL) in young adults.
(...)
During 40,260,757 person-months (PMs) of follow–up, 38,269 cases of HL and 5908 cases of SSNHL were identified.
(...)
Results
In the fully adjusted model, risks of HL (adjusted subdistribution hazard ratio [aSHR], 3.44; 95% CI, 3.33–3.56; P < 0.0001) and SSNHL (aSHR, 3.52; 95% CI, 3.23–3.83; P < 0.0001) were significantly higher in COVID-19 group compared to the non-COVID-19 group.
(...)
During 40,260,757 PMs of follow–up, 38,269 cases of HL were identified. Table 2 presents the association of COVID-19 with the risk of incident HL and SSNHL. The incidence of HL was 11.9/10,000 PMs in the COVID-19 group, which was over 3-fold higher than the non-COVID-19 group. Similarly, the incidence of SSNHL was over 3-fold higher in the COVID-19 group compared to the non-COVID-19 group. In the fully adjusted model, risks of HL (adjusted subdistribution hazard ratio [aSHR], 3.44; 95% CI, 3.33–3.56; P < 0.0001) and SSNHL (aSHR, 3.52; 95% CI, 3.23–3.83; P < 0.0001) were significantly higher in COVID-19 group compared to the non-COVID-19 group.
Incidence of hearing loss following COVID-19 among young adults in South Korea: a nationwide cohort study (The Lancet, July 29, 2024)


The South Korean study looked at young adults specifically, but the problem is probably not limited to them. Why would it be?
In the first quarter of 2022, the US hearing aid market has experienced tailwinds, lifting sales by 7.8 percent. This reflects that there is still demand left from when patients were unable to acquire devices during the pandemic, says an analyst writing for an industry media.
While hearing aid manufacturers can easily describe 2020 as a true annus horribilis, as their primary target customers are elderly people who largely avoided audiologists due to the imposing pandemic, the subsequent year has turned out very differently.
Pent-up demand for hearing aids continues to boost sales in US (MedWatch Hearing Health, April 29, 2022)

A faster growing hearing aid market than ever before and increasing reimbursement for hearing aids have been the hallmarks of the past few years in the U.S.
Focus on strong market and growing reimbursement at US hearing aid show (MedWatch Hearing Health, April 18, 2024)

Summary:
The global hearing aid market is expected to grow by $3.17 billion from 2024-2028, driven by technological advancements and rising demand, despite challenges like battery life concerns.
(...)
Rising Prevalence of Hearing Loss
The growing prevalence of hearing loss, particularly among the elderly, is fueling market growth. Innovations like invisible hearing aids, smart linked hearing aids, and AI-enabled hearing aids are gaining traction for their advanced and discreet solutions.
Hearing Aid Market Size to Grow Significantly Through 2028 (The Hearing Review, July 15, 2024)
See graph of Global Hearing Aid Market 2024-2028 in the linked article.


ETA: It is amusing to see how much the hearing-aid business still stresses how invisible and discreet its hearing aids are.
I had expected this to change nowadays when everybody is walking around with ear pods that are not at all invisible or discreet, but it hasn't happened yet.
 
Last edited:
The argument against the minimizers' idea that Long Covid is all in the head:
Abstract
Long COVID is a common sequela of SARS-CoV-2 infection. Data from numerous scientific studies indicate that long COVID involves a complex interaction between pathophysiological processes. Long COVID may involve the development of new diagnosable health conditions and exacerbation of pre-existing health conditions. However, despite this rapidly accumulating body of evidence regarding the pathobiology of long COVID, psychogenic and functional interpretations of the illness presentation continue to be endorsed by some healthcare professionals, creating confusion and inappropriate diagnostic and therapeutic pathways for people living with long COVID. The purpose of this perspective is to present a clinical and scientific rationale for why long COVID should not be considered as a functional neurologic disorder. It will begin by discussing the parallel historical development of pathobiological and psychosomatic/sociogenic diagnostic constructs arising from a common root in neurasthenia, which has resulted in the collective understandings of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and functional neurologic disorder (FND), respectively. We will also review the case definition criteria for FND and the distinguishing clinical and neuroimaging findings in FND vs. long COVID. We conclude that considering long COVID as FND is inappropriate based on differentiating pathophysiologic mechanisms and distinguishing clinical findings.
Keywords: post-COVID-19 condition (PCC); post-acute sequalae of COVID-19 (PASC); myalgic encephalomyelitis; chronic fatigue syndrome; neurasthenia; conversion disorder; dysautonomia; neurology; physical examination; imaging

1. Introduction
2. Pathobiological Disease Characterization: From Neurasthenia to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
3. Psychosomatic/Sociogenic Illness Construction: From Neurasthenia to Functional Neurologic Disorder
4. Evidence Refutes That Long COVID Should Be Considered a Functional Neurologic Disorder 4.1. Refutative Evidence from Pathophysiology 4.2. Refutative Evidence from Clinical Presentation 4.2.1. Motor Examination 4.2.2. Sensory Examination 4.2.3. Tremor 4.2.4. Spells and Seizures 4.2.5. Gait Examination 4.2.6. Urinary Functioning 4.2.7. Cognition 4.2.8. Summary 4.3. Refutative Evidence from Neuroimaging5. Conclusions
Author Contributions
Long COVID Is Not a Functional Neurologic Disorder (Journal of Personalized Medicine, July 6/July 23, 2024)
 
C19 and diabetes

Findings
16 669 943 people were included in the pre-vaccination cohort (Jan 1, 2020–Dec 14, 2021), 12 279 669 in the vaccinated cohort, and 3 076 953 in the unvaccinated cohort (both June 1–Dec 14, 2021). In the pre-vaccination cohort, aHRs for the incidence of type 2 diabetes after COVID-19 (compared with before or in the absence of diagnosis) declined from 4·30 (95% CI 4·06–4·55) in weeks 1–4 to 1·24 (1·14–1.35) in weeks 53–102. aHRs were higher in unvaccinated people (8·76 [7·49–10·25]) than in vaccinated people (1·66 [1·50–1·84]) in weeks 1–4 and in patients hospitalised with COVID-19 (pre-vaccination cohort 28·3 [26·2–30·5]) in weeks 1–4 declining to 2·04 [1·72–2·42] in weeks 53–102) than in those who were not hospitalised (1·95 [1·78–2·13] in weeks 1–4 declining to 1·11 [1·01–1·22] in weeks 53–102). Type 2 diabetes persisted for 4 months after COVID-19 in around 60% of those diagnosed. Patterns were similar for type 1 diabetes, although excess incidence did not persist beyond 1 year after a COVID-19 diagnosis.

Interpretation
Elevated incidence of type 2 diabetes after COVID-19 is greater, and persists for longer, in people who were hospitalised with COVID-19 than in those who were not, and is markedly less apparent in people who have been vaccinated against COVID-19. Testing for type 2 diabetes after severe COVID-19 and the promotion of vaccination are important tools in addressing this public health problem.
ncidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people (The Lancet: Diabetes & Endocrinology, August 2024)
aHRs = adjusted hazard ratios

Markedly less apparent in those vaccinated, but a considerable elevated incidence of type 2 diabetes after COVID-19 is nevertheless still there in the vaccinated, too.
 
Last edited:

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom